Synthego Announces CEO Transition to Focus on Enabling CRISPR Therapeutics

Leadership change simultaneous to the Eclipse Cell Engineering platform spinout as EditCo Bio REDWOOD CITY, Calif., March 27, 2024 /PRNewswire/ — Synthego Corporation, a leading provider of genome engineering solutions, announced that Paul Dabrowski will step down as Chief Executive…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks